Richard Peters
Presidente en APREA THERAPEUTICS, INC. .
Fortuna: 39 336 $ al 30/04/2024
Cargos activos de Richard Peters
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| APREA THERAPEUTICS, INC. | Independent Dir/Board Member | 30/06/2020 | - |
| Presidente | 23/08/2023 | - | |
| Director/Miembro de la Junta | 30/06/2020 | 23/08/2023 | |
| KINETA, INC. | Director/Miembro de la Junta | 19/12/2022 | - |
| Independent Dir/Board Member | 19/12/2022 | - | |
| PHARMING GROUP N.V. | Presidente | 25/09/2023 | - |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Director/Miembro de la Junta | - | - |
| Director Ejecutivo | - | - | |
| Presidente | - | - | |
Tellbio, Inc.
 Tellbio, Inc. BiotechnologyHealth Technology Tellbio, Inc. engages in biotechnology industry. The company is headquartered in West Newbury, MA. | Presidente | - | - |
| Fundador | - | - |
Historial de carrera de Richard Peters
Antiguos cargos conocidos de Richard Peters.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
PIC Therapeutics, Inc.
 PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Director/Miembro de la Junta | 01/03/2016 | 01/06/2022 |
| Fundador | 01/03/2016 | 01/06/2022 | |
| YUMANITY THERAPEUTICS | Director/Miembro de la Junta | 23/12/2020 | 01/01/2022 |
| Director Ejecutivo | 23/12/2020 | 01/01/2022 | |
| Presidente | 23/12/2020 | 01/01/2022 | |
| Secretario Corporativo | 23/12/2020 | 01/01/2022 | |
| Treasurer | 23/12/2020 | 01/01/2022 | |
| MERRIMACK PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 06/02/2017 | 28/06/2019 |
| Director Ejecutivo | 06/02/2017 | 28/06/2019 | |
| Director Financiero/CFO | 14/06/2017 | 21/08/2017 | |
| Presidente | 06/02/2017 | 28/06/2019 | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2008 | 01/01/2017 |
| ░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
Formación de Richard Peters.
| Medical University of South Carolina | Doctorate Degree |
| College of Charleston | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 16 |
| Países Bajos | 2 |
Operativa
| Director/Board Member | 7 |
| Founder | 5 |
| Chief Executive Officer | 4 |
Sectorial
| Health Technology | 14 |
| Consumer Services | 3 |
| Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 6 |
|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| APREA THERAPEUTICS, INC. | Health Technology |
| KINETA, INC. | Health Technology |
| PHARMING GROUP N.V. | Health Technology |
| Empresas privadas | 8 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
MedNav, Inc.
 MedNav, Inc. Packaged SoftwareTechnology Services MedNav, Inc. develops mobile health applications. | Technology Services |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Health Technology |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Health Technology |
PIC Therapeutics, Inc.
PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Health Technology |
Tellbio, Inc.
Tellbio, Inc. BiotechnologyHealth Technology Tellbio, Inc. engages in biotechnology industry. The company is headquartered in West Newbury, MA. | Health Technology |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. Its platform is based on technology, which enables the rapid screening for novel disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks, which usually results from an aberrant accumulation of misfolded proteins in the brain. The company was founded by Susan Lindquist and Tony Coles in December 2014 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Richard Peters
- Experiencia
